Table 6.
Treatment Group Mean Lag (±SD) |
||
---|---|---|
SVLs | PALs | |
Year 1 (SVLs vs. PALs) | ||
6-month visit | n = 43 | n = 40 |
Habitual Rx (no add) | 1.55 ± 0.45 | 1.55 ± 0.38 |
Habitual Rx with +2-D add | — | 1.22 ± 0.25 |
Lag reduction with add | — | 0.33 ± 0.34 |
12-month visit | n = 43 | n = 41 |
Habitual Rx (no add) | 1.54 ± 0.40 | 1.63 ± 0.41 |
Habitual Rx with +2-D add | — | 1.21 ± 0.27 |
Lag reduction with add | — | 0.42 ± 0.38 |
Mean lag experienced* | n = 43 | n = 41 |
1.55 ± 0.37 | 1.22 ± 0.21† | |
Year 2 (all wear SVLs) | ||
18-month visit | n = 41 | n = 39 |
Habitual Rx (no add) | 1.69 ± 0.62 | 1.67 ± 0.50 |
24-month visit | n = 42 | n = 41 |
Habitual Rx (no add) | 1.54 ± 0.35 | 1.70 ± 0.39 |
Mean lag experienced | n = 42 | n = 41 |
1.61 ± 0.40† | 1.68 ± 0.40 † |
Habitual prescription is defined as the prescription in the study spectacles worn to the visit.
Mean of the 6-month and 12-month habitual lag values when wearing the assigned spectacle type (SVL [habitual Rx] or PAL [habitual Rx with +2-D add]).
For children not seen at the 6-month or 18-month visit, the 12-month or 24-month lag value, respectively, was used as the child's mean value.